1. Anti-infection
  2. RSV
  3. A 33903

A 33903 is a respiratory syncytial virus (RSV) replication inhibitor. A 33903 can be used for the research of RSV-infection.

For research use only. We do not sell to patients.

A 33903

A 33903 Chemical Structure

CAS No. : 70890-53-8

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

A 33903 is a respiratory syncytial virus (RSV) replication inhibitor. A 33903 can be used for the research of RSV-infection[1].

Cellular Effect
Cell Line Type Value Description References
HEp-2 CC50
> 50 μM
Compound: A-33903
Cytotoxicity against RSV RSS infected human Hep2 cells after 6 days by XTT assay
Cytotoxicity against RSV RSS infected human Hep2 cells after 6 days by XTT assay
[PMID: 17576833]
HEp-2 EC50
10.1 μM
Compound: A-33903
Antiviral activity against RSV RSS infected human Hep2 cells assessed as reduction of viral antigen synthesis after 3 days by ELISA
Antiviral activity against RSV RSS infected human Hep2 cells assessed as reduction of viral antigen synthesis after 3 days by ELISA
[PMID: 17576833]
HEp-2 EC50
15.1 μM
Compound: A-33903
Antiviral activity against RSV A2 infected human Hep2 cells after 5 days by plaque reduction assay
Antiviral activity against RSV A2 infected human Hep2 cells after 5 days by plaque reduction assay
[PMID: 17576833]
HEp-2 EC50
27.6 μM
Compound: A-33903
Antiviral activity against plaque picked A-33903-resistant RSV RSS from passage 2 in human Hep2 cells by plaque reduction assay
Antiviral activity against plaque picked A-33903-resistant RSV RSS from passage 2 in human Hep2 cells by plaque reduction assay
[PMID: 17576833]
HEp-2 EC50
3.5 μM
Compound: A-33903
Antiviral activity against RSV B infected human Hep2 cells after 5 days by plaque reduction assay
Antiviral activity against RSV B infected human Hep2 cells after 5 days by plaque reduction assay
[PMID: 17576833]
HEp-2 EC50
7.2 μM
Compound: A-33903
Antiviral activity against RSV Long infected human Hep2 cells after 5 days by plaque reduction assay
Antiviral activity against RSV Long infected human Hep2 cells after 5 days by plaque reduction assay
[PMID: 17576833]
HEp-2 EC50
8.1 μM
Compound: A-33903
Antiviral activity against DMSO-passaged wild type RSV RSS infected human Hep2 cells by plaque reduction assay
Antiviral activity against DMSO-passaged wild type RSV RSS infected human Hep2 cells by plaque reduction assay
[PMID: 17576833]
HEp-2 EC50
9.6 μM
Compound: A-33903
Antiviral activity against RSV RSS infected human Hep2 cells assessed as inhibition of virus-induced cell death after 6 days by XTT assay
Antiviral activity against RSV RSS infected human Hep2 cells assessed as inhibition of virus-induced cell death after 6 days by XTT assay
[PMID: 17576833]
HEp-2 EC50
9.7 μM
Compound: A-33903
Antiviral activity against RSV RSS infected human Hep2 cells after 5 days by plaque reduction assay
Antiviral activity against RSV RSS infected human Hep2 cells after 5 days by plaque reduction assay
[PMID: 17576833]
HEp-2 EC50
> 100 μM
Compound: A-33903
Antiviral activity against plaque picked RSV604-resistant RSV RSS from passage 2 in human Hep2 cells by plaque reduction assay
Antiviral activity against plaque picked RSV604-resistant RSV RSS from passage 2 in human Hep2 cells by plaque reduction assay
[PMID: 17576833]
HEp-2 IC50
17.6 μM
Compound: 18
Antiviral activity against RSV Long in Hep2 cells by ELISA
Antiviral activity against RSV Long in Hep2 cells by ELISA
[PMID: 16570927]
HEp-2 IC50
17.8 μM
Compound: 18
Antiviral activity against RSV B in Hep2 cells by ELISA
Antiviral activity against RSV B in Hep2 cells by ELISA
[PMID: 16570927]
HEp-2 IC50
3.6 μM
Compound: 18
Antiviral activity against RSV B in Hep2 cells by plaque assay
Antiviral activity against RSV B in Hep2 cells by plaque assay
[PMID: 16570927]
HEp-2 IC50
7.1 μM
Compound: 18
Antiviral activity against RSV RSS in Hep2 cells by plaque assay
Antiviral activity against RSV RSS in Hep2 cells by plaque assay
[PMID: 16570927]
HEp-2 IC50
7.2 μM
Compound: 18
Antiviral activity against RSV Long in Hep2 cells by plaque assay
Antiviral activity against RSV Long in Hep2 cells by plaque assay
[PMID: 16570927]
HEp-2 IC50
8.6 μM
Compound: 18
Antiviral activity against RSV RSS in Hep2 cells by whole cell XTT assay
Antiviral activity against RSV RSS in Hep2 cells by whole cell XTT assay
[PMID: 16570927]
HEp-2 IC50
9.3 μM
Compound: 18
Antiviral activity against RSV RSS in Hep2 cells by ELISA
Antiviral activity against RSV RSS in Hep2 cells by ELISA
[PMID: 16570927]
Sf9 IC50
> 10 μM
Compound: figure 3, R4C2
Displacement of [3H]Ro15-4513 from GABAA alpha-1-beta-2-gamma-2 receptor expressed in Sf9 baculovirus system
Displacement of [3H]Ro15-4513 from GABAA alpha-1-beta-2-gamma-2 receptor expressed in Sf9 baculovirus system
[PMID: 18537233]
Sf9 IC50
> 10 μM
Compound: figure 3, R4C2
Displacement of [3H]Ro15-4513 from GABAA alpha-5-beta-2-gamma-2 receptor expressed in Sf9 baculovirus system
Displacement of [3H]Ro15-4513 from GABAA alpha-5-beta-2-gamma-2 receptor expressed in Sf9 baculovirus system
[PMID: 18537233]
Molecular Weight

293.32

Formula

C17H15N3O2

CAS No.
SMILES

O=C(C)NC1N=C(C2=C(NC1=O)C=CC=C2)C3=CC=CC=C3

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
A 33903
Cat. No.:
HY-108002
Quantity:
MCE Japan Authorized Agent: